There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

There is emerging interest in adaptive platform trials for inflammatory bowel disease. In this Comment, we present the results of a workshop that was convened to consider the opportunities and ...

Biofrontera Inc. reports a record $37.3M in 2024 revenue, FDA milestones, and strategic growth plans for 2025.

Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a subgroup of breast cancer patients, but not the overall study population.

Seven members of the medical team that treated Diego Maradona before his death will today go on trial for homicide in ... tended to the former athlete and clinical physician Pedro Pablo Di Spagna.

A jury on Monday sided with Disney in a copyright trial involving “Moana,” clearing the company of an infringement suit brought by a screenwriter. The plaintiff, Buck Woodall, filed suit in ...

The STARI trial (NCT06832306), a Phase 2 feasibility study ... to investigational use. Used exclusively for clinical investigations.

Ex-Aide to Georgia's Ivanishvili Flees Country to Escape Embezzlement Trial By Felix Light TBILISI (Reuters) - A former aide to Georgia's most powerful man has fled the country in the middle of ...

Opposition figures accused of conspiring against the state Accused say charges are fabricated by authoritarian leader Trial postponed to April 11 TUNIS, March 4 (Reuters) - The trial of prominent ...

Following immunization, participants’ NAb titers increased through Week 4 with a 2- to 4-fold increase from baseline, a clear and convincing response to the vaccination,” said Ai-ris Collier, M.D., Co ...

Camizestrant combination improves progression-free survival Trial to continue as planned after interim analysis Results "material positive surprise," say Barclays analysts Feb 26 (Reuters ...